SIM
AMRX icon

Spark Investment Management’s Amneal Pharmaceuticals AMRX Stock Holding History

Spark Investment Management’s Portfolio AMRX Stock Details AMRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-30,100
Closed -$143K – 53
2020
Q2 		$143K Sell
30,100
-106,558
-78% -$439K 0.52% 41
2020
Q1 		$475K Sell
136,658
-46,642
-25% -$198K 0.25% 136
2019
Q4 		$883K Sell
183,300
-141,141
-44% -$491K 0.1% 268
2019
Q3 		$940K Sell
324,441
-83,159
-20% -$290K 0.12% 197
2019
Q2 		$2.92M Buy
407,600
+48,000
+13% +$491K 0.2% 158
2019
Q1 		$5.09M Buy
359,600
+211,000
+142% +$2.79M 0.24% 119
2018
Q4 		$2.01M Buy
+148,600
New +$2.68M 0.14% 204

Other funds holding AMRX

FI
Fosun International Hong Kong, China $446M AUM 13.33% 1-Year Est. Return
TGHSA
TPG Group Holdings (SBS) Advisors Fort Worth, Texas $10.1B AUM 22.58% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return
EP
Eversept Partners New York $1.93B AUM 160.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Spark Investment Management's AMRX Position: Q3 2020 in Review

Spark Investment Management sold out of Amneal Pharmaceuticals (AMRX) in Q3 2020, closing a stake of 30,100 shares — an estimated $143K sold.

Spark Investment Management first reported a position in AMRX in Q4 2018 and held it in 7 quarters. The position peaked at $5.09M in Q1 2019. 140 funds tracked by Wall St. Rank hold AMRX as of Q3 2020.

  • Spark Investment Management reported no remaining Amneal Pharmaceuticals position as of Q3 2020 after selling out during the quarter.
  • Spark Investment Management sold 30,100 Amneal Pharmaceuticals shares in Q3 2020, an estimated $143K.
  • Spark Investment Management first reported a position in Amneal Pharmaceuticals in Q4 2018 and held it in 7 quarters.
  • Spark Investment Management's Amneal Pharmaceuticals position peaked at $5.09M in Q1 2019.
  • 140 funds tracked by Wall St. Rank held Amneal Pharmaceuticals as of Q3 2020.

Based on Spark Investment Management's 13F filing for Q3 2020, filed 12 Nov 2020.